Abscess formation within a synthetic hydroxyapatite orbital implant.
Jordan
D R
DR
University of Ottawa Eye Institute, Ont.
Klapper
S R
SR
Mawn
L
L
Brownstein
S
S
Punja
K
K
D000038:Abscess / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D000328:Adult; D000900:Anti-Bacterial Agents; D002830:Choroid Neoplasms / Q000601:surgery; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D017886:Durapatite; D015353:Eye Enucleation; D015818:Eye Infections, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008279:Magnetic Resonance Imaging; D008545:Melanoma / Q000601:surgery; D020273:Orbital Implants / Q000382:microbiology*; D016459:Prosthesis-Related Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D012086:Reoperation; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D013212:Staphylococcus epidermidis / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D017886:Durapatite